Basal Ganglia Pathophysiology
61 – 70 of 197
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Oral and infusion levodopa therapy in the management of Parkinson’s disease
(2016) p.63-75
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Signaling mechanisms in L-DOPA-induced dyskinesia
(2016) p.155-188
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
A Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine
- Contribution to journal › Article
-
Mark
Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and l-DOPA-induced dyskinesia.
- Contribution to journal › Article
-
Mark
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
- Contribution to journal › Scientific review
-
Mark
Zooming in on the small: The plasticity of striatal dendritic spines in l-DOPA-Induced dyskinesia.
- Contribution to journal › Article
-
Mark
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.
- Contribution to journal › Article
-
Mark
Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
- Contribution to journal › Scientific review
-
Mark
NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
- Contribution to journal › Article
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
- Contribution to journal › Article
